Home

Efficacy of Soberana 02 and Soberana Plus three-dose scheme achieves 91.2%

The efficacy of the Soberana 02 vaccine candidate in its three-dose schedule together with Soberana Plus is 91.2%, which exceeds the World Health Organization (WHO) requirements for a vaccine candidate against COVID-19 to become a vaccine, which is 50%.

July 9, 2021
Written by RHC
Category: Health
Hits: 1172

US magazine praises Cuba´s Soberana 02 vaccine candidate

Design, obtaining and preclinical assessment of Cuban anti-Covid Soberana 02 vaccine candidate reached the headlines of the US magazine ACS Chemical Biology, paving the way for other antiviral vaccines.

July 6, 2021
Written by Redacción ¡ahora!
Category: Health
Hits: 1146

Umelisa SARS-COV-2 antigen, a 100 % Cuban diagnostic system

The Immunoassay Center has developed a new product to diagnose the Sars-Cov-2 virus.

July 5, 2021
Written by RHC
Category: Health
Hits: 1495

Cuba Declares Community Transmission Phase for COVID-19

Cuban Public Health Minister Jose Angel Portal Miranda informed that the country is now under the community transmission phase for COVID-19 given the high contagious impact by the virus and the increase of its incidence levels over the past 15 days, add to this the circulation of highly contagious variants of the SARS-CoV-2.

June 30, 2021
Written by ACN
Category: Health
Hits: 1007